Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Neurosci Lett. 2021 Feb 6;745:135627. doi: 10.1016/j.neulet.2021.135627. Epub 2021 Jan 10.
The review article briefly discusses a hypothesis based on the potential participation of iron dyshomeostasis and iron-mediated cell death (ferroptosis) in the pathogenesis of some neurodegenerative diseases. Iron dyshomeostasis (especially cellular iron overload) is considered to be a critical condition of neurodegeneration. The etiopathogenesis of many neurodegenerative diseases including Alzheimer's and Parkinson's diseases, Multiple sclerosis, and others, is different. However, there are several identical cellular processes, such as iron dyshomeostasis (an excessive iron deposition), iron-induced oxidative stress, the accumulation of lipid-generated reactive oxygen species, and ferroptosis that accompany these diseases. Based on the existing theoretical and experimental evidence, the article provides current insight into iron dyshomeostasis and ferroptosis as a contributing factor to the pathogenesis of neurodegeneration. In addition, special attention is addressed to the possible relationship between cellular iron overload and key pathological features of selected neurodegenerative diseases, such as β-amyloid and tau proteins, α-synuclein, and demyelination. The mechanism by which ferroptosis may be involved in the pathogenesis of various neurodegenerative diseases is not fully elucidated. Further experimental and clinical studies are needed to clarify the hypothesis on the potential role of ferroptosis in the pathogenesis of neurodegenerative diseases.
这篇综述文章简要讨论了一个假说,即铁代谢失衡和铁介导的细胞死亡(铁死亡)可能参与了一些神经退行性疾病的发病机制。铁代谢失衡(尤其是细胞内铁过载)被认为是神经退行性变的关键条件。包括阿尔茨海默病和帕金森病、多发性硬化症等在内的许多神经退行性疾病的病因发病机制各不相同。然而,有几个相同的细胞过程伴随着这些疾病,如铁代谢失衡(铁过度沉积)、铁诱导的氧化应激、脂质产生的活性氧物质的积累以及铁死亡。基于现有的理论和实验证据,本文提供了目前对铁代谢失衡和铁死亡作为神经退行性变发病机制的一个促成因素的见解。此外,还特别关注细胞铁过载与选定神经退行性疾病的关键病理特征(如β-淀粉样蛋白和tau 蛋白、α-突触核蛋白和脱髓鞘)之间的可能关系。铁死亡如何参与各种神经退行性疾病的发病机制尚不完全清楚。需要进一步的实验和临床研究来阐明铁死亡在神经退行性疾病发病机制中的潜在作用假说。